Ultragenyx Pharma (RARE) PT Raised to $90 at Stifel
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $34.23 +11.57%
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 19
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 19
Join SI Premium – FREE
Stifel raised its price target on Ultragenyx Pharma (NASDAQ: RARE) to $90.00 (from $77.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FTAI Infrastructure (FIP) PT Lowered to $12 at Compass Point
- Curbline Properties Corp (CURB) PT Raised to $32.50 at Stifel
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK285 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
